deltatrials
Completed OBSERVATIONAL NCT02305732

A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components (TRUE)

Sponsor: American National Red Cross

Conditions Chikungunya Virus Dengue Virus
Interventions INTERCEPT Platelets
Updated 11 times since 2017 Last updated: Jan 24, 2018 Started: Mar 31, 2015 Primary completion: May 31, 2016 Completion: May 31, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chikungunya Virus and Dengue Virus, this trial is completed. The trial is conducted by American National Red Cross and has accumulated 11 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Apr 2018 · 14 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshotCompleted~Nov 2018 – ~Jan 2021 · 26 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 11 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2023 — Jul 2024 [monthly]

    Completed

  5. Dec 2022 — Jan 2023 [monthly]

    Completed

▶ Show 6 earlier versions

  1. Jan 2021 — Dec 2022 [monthly]

    Completed

  2. Nov 2018 — Jan 2021 [monthly]

    Completed

  3. Jun 2018 — Nov 2018 [monthly]

    Completed

  4. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

  5. Feb 2017 — Apr 2018 [monthly]

    Completed NA

  6. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • American National Red Cross
  • Cerus Corporation
Data source: Cerus Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations